These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33899502)

  • 1. Recent Advances and Current Dilemmas in the Diagnosis and Management of Transthyretin Cardiac Amyloidosis.
    Addison D; Slivnick JA; Campbell CM; Vallakati A; Jneid H; Schelbert E
    J Am Heart Assoc; 2021 May; 10(9):e019840. PubMed ID: 33899502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
    Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis.
    Gopal DM; Ruberg FL; Siddiqi OK
    Curr Heart Fail Rep; 2019 Oct; 16(5):180-188. PubMed ID: 31520266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to Identify Transthyretin Cardiac Amyloidosis at an Early Stage.
    Izumiya Y; Hayashi H; Ishikawa H; Shibata A; Yoshiyama M
    Intern Med; 2021 Jan; 60(1):1-7. PubMed ID: 32713926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
    Rigopoulos AG; Ali M; Abate E; Torky AR; Matiakis M; Mammadov M; Melnyk H; Vogt A; de Vecchis R; Bigalke B; Wohlgemuth W; Mavrogeni S; Noutsias M
    Heart Fail Rev; 2019 Jul; 24(4):521-533. PubMed ID: 30790171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac amyloidosis: an update on diagnosis, current therapy, and future directions.
    Khedraki R
    Curr Opin Cardiol; 2022 May; 37(3):272-284. PubMed ID: 35612939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope.
    González-López E; López-Sainz Á; Garcia-Pavia P
    Rev Esp Cardiol (Engl Ed); 2017 Nov; 70(11):991-1004. PubMed ID: 28870641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transthyretin Cardiac Amyloidosis in Older Adults: Optimizing Cardiac Imaging to the Corresponding Diagnostic and Management Goal.
    Castaño A; Manson DK; Maurer MS; Bokhari S
    Curr Cardiovasc Risk Rep; 2017 Jun; 11():. PubMed ID: 29057029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Diagnosis and Treatment of Cardiac and Renal Amyloidosis.
    Law S; Fontana M; Gillmore JD
    Cardiol Clin; 2021 Aug; 39(3):389-402. PubMed ID: 34247752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid transthyretin cardiac amyloidosis with different manifestations, test findings and types.
    Budweg J; Al-Ani M; Assaf Y; Parker A; Aranda J
    BMJ Case Rep; 2023 Apr; 16(4):. PubMed ID: 37080632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis.
    Puig-Carrion GD; Reyentovich A; Katz SD
    Clin Auton Res; 2019 Sep; 29(Suppl 1):45-53. PubMed ID: 31452023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute cardiac failure secondary to senile systemic amyloidosis.
    Bodard Q; Roca F; Dilly B; Laurent D; Chassagne P
    Age Ageing; 2016 Nov; 45(6):908-909. PubMed ID: 27103598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac amyloidosis: An update on diagnosis and treatment.
    Donnelly JP; Hanna M
    Cleve Clin J Med; 2017 Dec; 84(12 Suppl 3):12-26. PubMed ID: 29257735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid cardiomyopathy.
    Kristen AV
    Herz; 2020 May; 45(3):267-271. PubMed ID: 32107564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodality Imaging in Cardiac Amyloidosis.
    Giblin GT; Cuddy SAM
    Curr Cardiol Rep; 2021 Aug; 23(10):134. PubMed ID: 34410523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tafamidis for the treatment of transthyretin amyloidosis.
    Lorenzini M; Elliott PM
    Future Cardiol; 2019 Mar; 15(2):53-61. PubMed ID: 30767672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy.
    Galant NJ; Westermark P; Higaki JN; Chakrabartty A
    Clin Sci (Lond); 2017 Mar; 131(5):395-409. PubMed ID: 28213611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transthyretin Cardiac Amyloidosis in Older Americans.
    Brunjes DL; Castano A; Clemons A; Rubin J; Maurer MS
    J Card Fail; 2016 Dec; 22(12):996-1003. PubMed ID: 27769906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial Effect of Pimobendan for Severe Heart Failure Due to Transthyretin Cardiac Amyloidosis.
    Okamoto N; Kubo T; Nakashima Y; Ochi Y; Takahashi A; Baba Y; Hirota T; Yamasaki N; Kitaoka H
    Intern Med; 2020 Feb; 59(3):339-343. PubMed ID: 31588087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.